Control of the Proinflammatory State in Cystic Fibrosis Lung Epithelial Cells by Genes from the TNF-αR/NFκB Pathway

Molecular Medicine

Volumn 7, Issue 8, 2001, Pages 523-534

  Eidelman, Ofer ^a   Srivastava, Meera ^a   Zhang, Jian ^a   Leighton, Ximena ^a   Murtie, Joshua ^a   Jozwik, Catherine ^a   Jacobson, Ken ^b   Weinstein, Debra L ^a   Metcalf, Eleanor L ^a   Pollard, Harvey B ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; CFTR PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR RECEPTOR; XANTHINE DERIVATIVE;

ALGORITHM; ARTICLE; BIOLOGICAL MODEL; CELL LINE; CHILD; CLUSTER ANALYSIS; CYSTIC FIBROSIS; DNA MICROARRAY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; HUMAN; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT MUCOSA; SECRETION; TIME;

ALGORITHMS; CELL LINE; CHILD; CLUSTER ANALYSIS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GENE THERAPY; HUMANS; INTERLEUKIN-8; LUNG; MODELS, BIOLOGICAL; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PSEUDOMONAS AERUGINOSA; RECEPTORS, TUMOR NECROSIS FACTOR; RESPIRATORY MUCOSA; TIME FACTORS; XANTHINES;

EID: 0035431701     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401858     Document Type: Article

References (37)

1. Welsh MJ, Ramsey BW, Accurso F and Cutting G. (2001) Cystic Fibrosis. In Scriver CL, Beaudet AL, Valle D, Sly WS, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th ed. New York: McGraw-Hill pp. 5121-5188.
2. Rommens JM, Lannuzzi MC, Karem B-S, et al. (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059-1065.
3. Riordan JR, Rommens JM, Karem B-S, et al. (1989) Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245: 1066-1073.
4. Kerem B-S Rommens JM, Buchanan JA, et al. (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073-1080.
5. Cheng SH, Gregory RJ, Marshall J, et al. (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63: 827-834.
6. Lukacs GL, Mohamed A, Kartner N, Chang X-B, Riordan JR, Grinstein S. (1994) Conformational maturation of CFTR but not its mutant counterpart (ΔF508) occurs in the endoplasmic reticulum and requires ATP. EMBO J. 13: 6076-6086.
7. Ward CL, Kopito RR. (1994) Intracellular turnover of Cystic Fibrosis Transmembrane Conductance Regulator. Inefficient processing and rapid degradation of wild type and mutant protein. J. Biol. Chem. 269: 25710-25718.
8. Yang Y, Janich S, Cohn JA, Wilson JM. (1993) The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment. Proc. Natl. Acad. Sci. U.S.A. 90: 9480-9484.
9. Eidelman O, Guay-Broder C, van Galen PJM, et al. (1992) Al adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells. Proc. Natl. Acad. Sci. U.S.A. 89: 5562-5566.
10. Rubenstein RC, Zeitlin PL. (2000) Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of ΔF508-CFTR. Am. J. Physiol. Cell Physiol 278: C259-C267.
11. Dean TP, Dai Y, Shute JK, Church MK, Warner JO. (1993) Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum and sera of children with cystic fibrosis. Pediatr. Res. 34: 159-161.
12. DiMango E, Ratner AJ, Bryan R, Tabibi S, Prince A. (1998) Activation of NFκB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J. Clin. Invest. 101: 2598-2605.
13. Francoeur C, Denis M. (1995) Nitric oxide and interleukin-8 as inflammatory components of cystic fibrosis. Inflammation 19: 587-598.
14. Richman-Eisenstat JB, Jorens PG, Hebert CA, Ueki I, Nadel JA. (1993) Interleukin-8: an important chemoattractant In sputum of patients with chronic inflammatory airway diseases. Am. J. Physiol. 264: L413-L418.
15. Briars GL, Dean TP, Murphy JL, Rolles CJ, Warner JO. (1995) Faecal interleukin-8 and tumour necrosis factor- alpha concentrations in cystic fibrosis. Arch. Dis. Child. 73: 74-76.
16. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. (1995) Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151: 1075-1082.
17. Srivastava M, Eidelman O, Pollard HE. (1999) Pharmacogenomics of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and the Cystic Fibrosis Drug CPX using genome microarray analysis. Mol. Med. 5: 753-767.
18. Weinstein DL, O'Neill B, Metcalf ES. (1997) Salmonella typhi stimulation of human intestinal epithelial cells induces secretion of epithelial cell-derived interleukin-6. Infect. Immun. 65: 395-404.
19. Eisen MB, Spellman FT, Brown PO, Botstein D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95: 14863-14868.
20. Egan M, Flotte T, Afione S, et al. (1992) Defective regulation of outwardly rectifying Cl-channels by protein kinase A corrected by insertion of CFTR. Nature 358: 581-584.
21. Venkatakrishnan A, Stecenko AA, King G, et al. (2000) Exaggerated activation of nuclear factor κB and altered IκB-β processing in cystic fibrosis bronchial epithelial cells. Am. J. Respir. Cell. Mol. Biol. 23: 396-403.
22. Casavula V, Turner RJ, Guay-Boder C, Jacobson KA, Eidelman O, Pollard HB. (1995) CPX, a selective Al-adenosine-receptor antagonist, regulates intracellular pH in cystic fibrosis cells. Am. J. Physiol. 269: C226-C233.
23. Arispe N, Ma J, Jacobson KA, Pollard HB. (1998) Direct activation of Cystic Fibrosis Transmembrane Conductance Regulator by 8-cyclopentyl-1,3-dipropylxanthine and 1,3- Diallyl-8-cyclohexylxanthine. J. Biol Chem. 273: 5724-5734.
24. Maiuri L, Raia V, De Marco G, et al. (1997) DNA fragmentation is a feature of cystic fibrosis epithelial cells: a disease with inappropriate apoptosis? FEBS Lett. 408: 225- 231.
25. Durieu I, Amsellem C, Paulin C, et al. (1999) Fas and Fas ligand expression in cystic fibrosis airway epithelium. Thorax 54: 1093-1098.
26. Gottlieb RA, Dasanjh A. (1996) Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C127 cells possible relevance to cystic fibrosis. Proc. Natl. Acad. Sci. U.S.A. 93: 3587-3591.
27. Denning GM, Wollenweber LA, Railsback MA, Cox CD, Stoll LL, Britigan BE. (1998) Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells. Infect. Immun. 66: 5777-5784.
28. Epelman S, Bruno TF, Neely GG, Woods DE, Mody CH. (2000) Pseudomonas aeruginosa exoenzyme S induces transcriptional expression of pro-inflammatory cytokines and chemokines. Infect. Immun. 68: 4811-4814.
29. Schweibert LM, Estell K, Propst SM. (1999) Chemokine expression in CF epithelia: implications for the role of CFTR in RANTES expression. Am. J. Physiol. 276: C700-C710.
30. Corrin B, Butcher D, McAnulty BJ, et al. (1994) Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Histopathology 24: 145-150.
31. Arkwright PD, Laurie S, Super M, et al. (2000) TGF-beta(1) genotype and accelerated decline in lung function in patients with cystic fibrosis. Thorax 55: 459-462.
32. Wojnarowski C, Frischer T, Hofbauer E, et al. (1999) Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation. Eur. Respir. J. 14: 1136-1144.
33. Short DB, Trotter KW, Reczek D, et al. (1998) An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J. Biol. Chem. 273: 19797-19801.
34. Moyer BD, Denton J, Karlson KH, et al. (1999) A PDZ- interacting domain in CFTR is an apical membrane polarization signal. J. Clin. Inv. 104: 1353-1361.
35. Sun F, Hug MJ, Bradbury NA, Frizzell RA. (2000) E3KARP mediates the association of ezrin and protein kinase A with the cystic fibrosis transmembrane conductance regulator in airway cells. J. Biol. Chem. 275: 29539- 29546.
36. Sun F, Hug MJ, Lewarchik CM, Yun C, Bradbury NA, Frizzell RA. (2000) Protein kinase A associates with cystic fibrosis transmembrane conductance regulator via an interaction with ezrin. J. Biol. Chem. 275: 14360-14366.
37. Rothwarf DM, Karin M. (1999) The NFκB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus. Science's STKE available at: http:// www.stke.org/cgi/content/full/OC_sigtrans;1999/5/re1